.Cancer firm Oncternal Therapies is folding all its scientific trials and laying off personnel, turn...
.Roche is storing out chances that its injectable obesity possibility might inevitably display 25% f...
.Novo Nordisk has raised the lid on a period 1 test of its own dental amylin as well as GLP-1 recept...
.Only a few brief weeks after succeeding an FDA Fast Track tag for its own investigational BTK degra...
.Not long after a positive information decrease for Eli Lilly's efsitora alfa, the Indianapolis-base...
.BridgeBio Pharma is lowering its gene treatment spending plan and pulling back from the modality af...
.GSK's attempt to develop the first injection for genital herpes simplex virus (HSV) has finished in...
.GSK's long-acting bronchial asthma procedure has actually been actually shown to cut in half the am...
.AstraZeneca and Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has stopped working t...
.Matt Gline is back with a brand-new 'vant' firm, after the Roivant Sciences CEO paid for Bayer $14 ...